<DOC>
	<DOCNO>NCT02468037</DOCNO>
	<brief_summary>High tissue iron risk factor diabetes even within broad normal range normal human value . In order demonstrate benefit reduce iron glucose homeostasis well define parameter large clinical trial , investigator subject individual prediabetes ( impaired glucose tolerance , IGT ) early type 2 diabetes phlebotomy order reduce serum ferritin concentration determine effect glucose homeostasis reveal oral frequently sample intravenous glucose tolerance testing .</brief_summary>
	<brief_title>Effect Iron Reduction Phlebotomy Type 2 Diabetes</brief_title>
	<detailed_description>Male female subject age 35-65 recruit clinic population Medical Centers Universities Colorado , New Mexico , Utah prediabetes , diabetes relatively well-controlled ( Hemoglobin A1c [ HbA1c ] ≤ 8.0 % ) single oral agent . Diabetes/prediabetes status verified oral glucose tolerance testing ( OGTT ) use criteria American Diabetes Association . Serum ferritin determine , subject choose value upper 50 % normal range , 110-400 ng/mL male , 80-240 female . Exclusion criterion include : hereditary hemochromatosis ; cancer ( except case currently evidence disease ) ; serum creatinine &gt; 1.5 ; anemia ( Hgb &lt; low limit normal ) ; chronic inflammatory condition ( rheumatologic condition rheumatoid arthritis giant cell arteritis , chronic infection hepatitis B C ) could affect ferritin ; erythrocyte sedimentation rate C-reactive protein &gt; 1.5 time upper limit normal ( UNL ) ; serum transaminases 2 x UNL ; hemophilia , warfarin therapy , history GI bleeding ; current glucocorticoid therapy . After determination eligibility , subject randomized 2:1 ratio treatment control arm . In fasted state , blood drawn determination adiponectin lipid ( HDL , direct LDL , triglyceride ) . Subjects option participate frequently sample intravenous glucose tolerance test ( FSIVGTT ) . All subject receive counsel follow healthy diet regular exercise . Phlebotomy occur rate 500 ml ( one Unit ) blood per month period 3-6 month . At two-month interval , serum ferritin complete blood count determine . When serum ferritin reach low quartile normal ( &lt; 50 ng/mL female &lt; 70 ng/mL male , sooner 3 month later 6 month begin phlebotomy , metabolic status reassess fast lipid , adiponectin , OGTT , optionally , FSIVGTT . Controls recall repeat test 6-8 month enrollment . 120 min OGTT FSIVGTT perform separate day overnight fast . FSIVGTT data analyze use MINMOD Millennium software . Areas glucose curve ( AUCglucose ) calculate use trapezoidal method .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<criteria>Age 3565 Prediabetes , diabetes relatively wellcontrolled ( Hemoglobin A1c [ HbA1c ] ≤ 8.0 % ) single oral agent define oral glucose tolerance testing ( OGTT ) use criteria American Diabetes Association . Serum ferritin value upper 50 % normal range , 110400 ng/mL male , 80240 female . hereditary hemochromatosis ; cancer ( except case currently evidence disease ) ; serum creatinine &gt; 1.5 ; anemia ( Hgb &lt; low limit normal ) ; chronic inflammatory condition ( rheumatologic condition rheumatoid arthritis giant cell arteritis , chronic infection hepatitis B C ) could affect ferritin ; erythrocyte sedimentation rate Creactive protein &gt; 1.5 time upper limit normal ( UNL ) ; serum transaminases 2 x UNL ; hemophilia , warfarin therapy , history GI bleeding ; current glucocorticoid therapy .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>iron</keyword>
	<keyword>diabetes</keyword>
	<keyword>phlebotomy</keyword>
</DOC>